Literature DB >> 31858286

Perspectives on the Medical, Quality of Life, and Economic Consequences of Hiccups.

Katharine Hendrix1, David Wilson2, M J Kievman3, Aminah Jatoi4.   

Abstract

PURPOSE OF REVIEW: Singultus or hiccups (HU) is a common, usually temporary, event. Its potentially serious consequences are often overlooked. This review explores published evidence describing HU burden (clinical, economic, and quality of life [QoL] consequences) across patient populations. RECENT
FINDINGS: Literature review identified 81 articles (including 57 individual case reports). We extracted relevant information to better understand the burden of HU and to identify knowledge gaps for future study. HU are physiologic events that can complicate existing medical conditions and treatments regardless of duration. Relatively short episodes can have devastating consequences in patients who have pre-existing conditions. HU appear to impact physical and psychological health, diminish QoL, increase healthcare resource use, and increase costs. A better understanding of HU burden is needed.

Entities:  

Keywords:  Burden of illness; Hiccoughs; Hiccups; Morbidity; Singultus

Mesh:

Year:  2019        PMID: 31858286     DOI: 10.1007/s11912-019-0857-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  85 in total

1.  Hiccups as an adverse reaction to cancer chemotherapy.

Authors:  Yuichi Takiguchi; Reiko Watanabe; Keiichi Nagao; Takayuki Kuriyama
Journal:  J Natl Cancer Inst       Date:  2002-05-15       Impact factor: 13.506

2.  Benztropine for the treatment of intractable hiccups: New indication for an old drug?

Authors:  Valorie L Cunningham
Journal:  CJEM       Date:  2002-05       Impact factor: 2.410

3.  Lidocaine for severe hiccups.

Authors:  M N Dunst; K Margolin; D Horak
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

4.  Treatment of resistant idiopathic hiccups with pulse radio frequency on phrenic nerve and gabapentin: A case report.

Authors:  O Ozturk; E Yavuz; B Yazicioglu; B Uzuner
Journal:  Niger J Clin Pract       Date:  2017-07       Impact factor: 0.968

5.  Baclofen therapy for chronic hiccup.

Authors:  C Guelaud; T Similowski; J L Bizec; J Cabane; W A Whitelaw; J P Derenne
Journal:  Eur Respir J       Date:  1995-02       Impact factor: 16.671

6.  Non-erosive reflux disease manifested exclusively by protracted hiccups.

Authors:  Andrés de Hoyos; Edgar A Esparza; María Cervantes-Sodi
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

Review 7.  Gender Differences in Hiccup Patients: Analysis of Published Case Reports and Case-Control Studies.

Authors:  Gyeong-Won Lee; Rock Bum Kim; Se Il Go; Hyun Seop Cho; Seung Jun Lee; David Hui; Eduardo Bruera; Jung Hun Kang
Journal:  J Pain Symptom Manage       Date:  2015-11-17       Impact factor: 3.612

8.  Intractable hiccups: the role of cerebral MR in cases without systemic cause.

Authors:  K Marsot-Dupuch; V Bousson; J Cabane; J M Tubiana
Journal:  AJNR Am J Neuroradiol       Date:  1995 Nov-Dec       Impact factor: 3.825

9.  Gabapentin in the treatment of persistent hiccups in advanced malignancy.

Authors:  Mahesh Menon
Journal:  Indian J Palliat Care       Date:  2012-05

10.  Intractable hiccups (singultus) abolished by risperidone, but not by haloperidol.

Authors:  Tadashi Nishikawa; Yoichiro Araki; Teruo Hayashi
Journal:  Ann Gen Psychiatry       Date:  2015-03-05       Impact factor: 3.455

View more
  1 in total

1.  Hiccups in patients with cancer: a multi-site, single-institution study of etiology, severity, complications, interventions, and outcomes.

Authors:  Christopher J Ehret; Yahya Almodallal; Jennifer G Le-Rademacher; Nichole A Martin; Michael R Moynagh; Arush Rajotia; Aminah Jatoi
Journal:  BMC Cancer       Date:  2022-06-15       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.